Total Funding
58
Total FundingSeed raised
Growth Score in past quarter
pts
Heat Score 58 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
73809
CNine Biosolutions focuses on the diagnostic potential of the complement system in infectious diseases.
- Theresa Schein: CEO / Co-FounderPast Role: University of Alabama at Birmingham, Scientist I
- Scott Barnum: CSOPast Role: The Scripps Research Institute, Postdoctoral Research Fellow
About the Company
CNine Biosolutions is a life science and biotechnology company that focuses on the diagnostic potential of the complement system in infectious diseases. The company believes complement biology offers fertile and unexplored targets for diagnostic management of the central nervous system.
It was founded in 2013 and headquartered in Birmingham,
Alabama.
Women Founded
Women Led